The cannabinoid CB<sub>1</sub> receptor antagonist SR141716 blocks the orexigenic effects of intrahypothalamic ghrelin
Sonia Tucci(University of Liverpool), Tim C. Kirkham(University of Liverpool), Márta Korbonits(Queen Mary University of London), Elizabeth K. Rogers(University of Liverpool)
Cited by 184
Related Papers
Cannabinoids and Ghrelin Have Both Central and Peripheral Metabolic and Cardiac Effects via AMP-activated Protein Kinase
|Journal of Biological Chemistry|2005|469
From pituitary adenoma to pituitary neuroendocrine tumor (PitNET): an International Pituitary Pathology Club proposal
|Endocrine Related Cancer|2017|357
International Union of Basic and Clinical Pharmacology. CV. Somatostatin Receptors: Structure, Function, Ligands, and New Nomenclature
|Pharmacological Reviews|2018|251
Nicotinic–serotonergic interactions in brain and behaviour
|Pharmacology Biochemistry and Behavior|2002|149
The role of lipid and carbohydrate digestive enzyme inhibitors in the management of obesity: a review of current and emerging therapeutic agents
|Diabetes Metabolic Syndrome and Obesity|2010|146